Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Geusens

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Current Osteoporosis Reports|February 26, 2009
Bisphosphonates for postmenopausal osteoporosis: determining duration of treatmentPiet Geusens
Clinical Interventions in Aging|June 26, 2009
Emerging treatments for postmenopausal osteoporosis - focus on denosumabPiet Geusens
Expert Opinion on Biological Therapy|April 28, 2009
Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD)Piet Geusens
Current Osteoporosis Reports|September 3, 2009
Glucocorticoid-induced osteoporosis: an indication for anabolic therapyPiet Geusens
Therapeutic Advances in Musculoskeletal Disease|August 4, 2012
The role of RANK ligand/osteoprotegerin in rheumatoid arthritisPiet Geusens
Best Practice & Research. Clinical Rheumatology|December 1, 2009
Strategies for treatment to prevent fragility fractures in postmenopausal womenPiet Geusens
RMD Open|November 12, 2015
New insights into treatment of osteoporosis in postmenopausal womenPiet Geusens
Therapeutics and Clinical Risk Management|August 30, 2008
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritisPiet Geusens, Willem Lems
Best Practice & Research. Clinical Rheumatology|November 23, 2005
Newer drug treatments: their effects on fracture preventionPiet Geusens, David Reid
Gender Medicine|December 25, 2007
Integrating a gender dimension into osteoporosis and fracture risk researchPiet Geusens, Geertjan Dinant
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Current Osteoporosis Reports|February 26, 2009
Bisphosphonates for postmenopausal osteoporosis: determining duration of treatmentPiet Geusens
Clinical Interventions in Aging|June 26, 2009
Emerging treatments for postmenopausal osteoporosis - focus on denosumabPiet Geusens
Expert Opinion on Biological Therapy|April 28, 2009
Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD)Piet Geusens
Current Osteoporosis Reports|September 3, 2009
Glucocorticoid-induced osteoporosis: an indication for anabolic therapyPiet Geusens
Therapeutic Advances in Musculoskeletal Disease|August 4, 2012
The role of RANK ligand/osteoprotegerin in rheumatoid arthritisPiet Geusens
Best Practice & Research. Clinical Rheumatology|December 1, 2009
Strategies for treatment to prevent fragility fractures in postmenopausal womenPiet Geusens
RMD Open|November 12, 2015
New insights into treatment of osteoporosis in postmenopausal womenPiet Geusens
Therapeutics and Clinical Risk Management|August 30, 2008
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritisPiet Geusens, Willem Lems
Best Practice & Research. Clinical Rheumatology|November 23, 2005
Newer drug treatments: their effects on fracture preventionPiet Geusens, David Reid
Gender Medicine|December 25, 2007
Integrating a gender dimension into osteoporosis and fracture risk researchPiet Geusens, Geertjan Dinant
Pageof 15